Bedriftssøk
Sign Up

VIDUNDERLIG PHARMACEUTICALS AS

929760352Aksjeselskap
Municipality
OSLO
Founded
20.08.2022
Roles
2
Company details
Business address
Falbes gate 18A, 0170 OSLO
Municipality
Oslo
Sector
Private aksjeselskaper mv.
Share capital
30 000 kr(1 000 shares)
Registered
02.09.2022
Purpose
Utvikling av antistoff-legemiddel konjugat (ADC)- medisin mot HER2(reseptor tyrosine-protein kinase erbB-2), receptor tyrosine-protein kinase erbB-3(HER3) og Tumor-associated calcium signal transducer 2(TROP-2/TACSTD2) positiv brystkreft samt ADC-medisin mot myelomatose og mantle cell lymphom.
Board and management
Muisha Rodrig Shekobe Balingene
Daglig lederStyrets leder

Relationship graph

Explore in 3D
Loading graph...
Click a node to navigate. Drag to move. Company PersonStyreDaglig lederRevisorRegnskapInnehaverOpen in 3D →
Financials2024
Net result
0
Assets
0
Equity
30.0 mill
Debt
0
Financial health check
Equity ratio
—
—
Current ratio
—
—
Profitability
—
—
Income statement and balance sheet
2024
Income statement
Revenue—
Operating costs—
= Operating result—
Net finance—
= Net result0
Balance sheet
Fixed assets0
Current assets0
= Total assets0
Equity30.0 mill
Long-term debt0
Short-term debt0
= Total debt0

Source: Brønnøysund Register Centre

Key Ratios
2024Industry (median)
Operating margin
—-3.7%
Net margin
——
Return on assets
—-0.2%
Return on equity
0.0%—
Equity ratio
—50.7%
Current ratio
—1.90
Debt-to-equity
0.000.62

Based on 648 companies

Source: Brønnøysund Register Centre. Ratios are calculated using universal formulas.

Powered by Webagent — digital solutions for Norwegian businesses

Powered by Webagent